ANI Pharmaceuticals reported $2K in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
ANI Pharmaceuticals USD 2K 0 Mar/2025
Aurora Cannabis CAD 56.25M 6.92B Jun/2025
Canopy Growth CAD 205.15M 8.47B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Novartis USD 1.94B 1.14B Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Sun Pharmaceuticals INR 2.4B 0 Mar/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025